complicates fda filing...most certainly
You heard the clinicians say that the AE profile is moderate, similar to other agents that impact angiogenesis?
Yes, FDA is always concerned on safety issues. See BMTI after after panel negative comments about saftey and see now where it is closed today. $14 - $6.64SAFETY A PRIME CONCERN FOR FDA.
Its cancer, untreatable cancer. Hello. really!!